VitaNova Life Sciences (VNOV) Debt Ratio (2017 - 2023)

VitaNova Life Sciences (VNOV) posted Debt Ratio of 1.46 for Q1 2023, up 325.16% on a QoQ basis from 0.34 in Q4 2022, and up 411.18% year-over-year from 0.29 in Q1 2022.

VitaNova Life Sciences (VNOV) Debt Ratio (2017 - 2023) Analysis & Trends

VitaNova Life Sciences' Debt Ratio history runs 5 years deep, the most recent figure standing at 1.46 for Q1 2023.

  • Quarterly Debt Ratio rose 411.18% year-over-year to 1.46 in Q1 2023, while the trailing twelve-month figure through Jan 2023 was 1.46 (up 411.18% YoY) and the FY2022 annual result came in at 0.52, changed N/A from the prior year.
  • Debt Ratio was 1.46 for Q1 2023 at VitaNova Life Sciences, up from 0.34 in the prior quarter.
  • Across five years, Debt Ratio topped out at 1.46 in Q1 2023 and bottomed at 0.29 in Q1 2022.
  • A 3-year average of 0.57 and a median of 0.39 in 2021 frame the typical range for Debt Ratio.
  • Annual changes were most pronounced in 2022 — Debt Ratio decreased 9.94% — and 2023, when it soared 411.18%.
  • VitaNova Life Sciences' Debt Ratio stood at 0.38 in 2021, then declined by 9.94% to 0.34 in 2022, then jumped by 325.16% to 1.46 in 2023.
  • Business Quant data shows VNOV's Debt Ratio at 1.46 in Q1 2023, 0.34 in Q4 2022, and 0.4 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Mckesson 105.52 Bn 101.55 Bn 4.04 Bn 0.08
2 Cencora 60.84 Bn 58.66 Bn 3.59 Bn 0.15
3 Cardinal Health 53.88 Bn 49.95 Bn 2.50 Bn 0.16
4 Henry Schein 9.80 Bn 9.67 Bn 1.07 Bn 0.30
5 Akso Health 3.06 Bn 3.06 Bn - 0.00
6 111 651.73 Mn 572.63 Mn 23.58 Mn 0.09
7 Accendra Health 246.88 Mn -90.00 Mn 278.03 Mn 0.87
8 Edap Tms 228.64 Mn 213.64 Mn 8.15 Mn 0.26
9 VitaNova Life Sciences 11.51 Mn 11.01 Mn 316,343.00 -
10 Cosmos Health 9.34 Mn 7.18 Mn 1.38 Mn 0.15

Historic Data

Download Data
DateValue
Jan 31, 2023 1.46
Oct 31, 2022 0.34
Jul 31, 2022 0.40
Apr 30, 2022 0.52
Jan 31, 2022 0.29
Oct 31, 2021 0.38
Jan 31, 2018 0.17
Apr 30, 2017 2.37